Why the study?
What are the mechanisms and potential prevention strategies for thromboembolism in patients with breast cancer undergoing therapy?
What are the mechanisms and potential prevention strategies for thromboembolism in patients with breast cancer undergoing therapy?
This review highlights the prothrombotic state in breast cancer patients and emphasizes the need for thrombosis prophylaxis during high-risk interventions like surgery and chemotherapy.
No takes yet. Share an insight, caveat, or question.
May warrant individualized prophylaxis assessment during breast cancer therapy; leaves open optimal regimens pending prospective trials.
Caine et al. (2003) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: